微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -4.42% | -229.85% | 3.07% | 46/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -4.56% | -380% | -154.75% | 49/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -1.79% | -65.74% | 96.32% | 44/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -48.61% | -68.03% | -3527.61% | 49/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -1.34% | -103.26% | -41.05% | 45/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -0.95% | 33.57% | 12.04% | 43/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -1.08% | -325% | 96.27% | 43/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -28.93% | -49.74% | -170.29% | 46/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 41.16% | 6647.54% | 2978.32% | 1/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -1.43% | -3475% | -397.92% | 43/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 0.48% | 585.71% | 102.48% | 32/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -19.32% | -650.43% | -3267.21% | 45/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 0.61% | -82.96% | 1625% | 31/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -0.04% | -102.99% | -157.14% | 39/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.07% | 111.29% | -98.01% | 27/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 3.51% | -33.9% | -1.96% | 37/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 3.58% | -2.19% | 167.16% | 21/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 1.34% | -34.95% | 316.13% | 27/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -0.62% | -153.45% | -111.68% | 21/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 5.31% | -46.85% | 45.08% | 35/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 3.66% | -58.5% | 77.67% | 22/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 2.06% | -64.67% | 77.59% | 21/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 1.16% | -12.78% | -88.39% | 18/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 9.99% | 61.65% | 13.27% | 24/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 8.82% | 39.34% | 51.29% | 13/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 5.83% | 69.48% | 338.35% | 12/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.33% | -15.29% | -78.48% | 17/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 6.18% | -19.22% | -2.37% | 24/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 6.33% | -12.93% | 84.01% | 14/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 3.44% | -10.42% | 119.11% | 18/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 1.57% | -22.28% | -79.48% | 15/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 7.65% | -0.78% | 5.23% | 20/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 7.27% | 29.36% | 89.32% | 8/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 3.84% | 15.32% | 90.1% | 14/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 2.02% | 29.49% | -73.8% | 8/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 7.71% | 24.96% | 37.19% | 21/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 5.62% | 13.08% | 68.77% | 11/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 3.33% | 21.53% | 113.46% | 10/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 1.56% | 62.5% | -74.72% | 10/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |